Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
4D Pharma hopes to expand drug success to other areas
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:00:00
Kelechi R. Okoroha, M.D. Orthopedic Surgeon, Mayo Clinic
00:10:00
Specializes in game developers|Ed Fries,General Partner,1Up Ventures
00:10:00
Edward & Aparna: Sponsorship Stories at Kirkland | Jeffrey C. Hammes - CEO of Kirkland & Ellis LLP
00:10:00
Mobile Parts: Your Solution for Equipment Needs | Darren Bissonnette , Manager of Information Technology of Mobile Parts inc.
00:10:00
Puzzle Capital's Abrax Merger Arbitrage Fund, managed by Xavier Robinson, boasts a stellar track record with no negative years since its 2011 launch, focusing on avoiding deal breaks and generating double-digit annualized net returns.
00:10:00
Bardock Gold: Advancing a Tier-One Gold Project with 3 Million Ounces in Resources
00:10:00
Focused on technologies for the global real estate industry|Brad Greiwe, Managing Partner,Fifth Wall
00:10:00
Jonathan Pollock Discusses Crypto, China, and Global Markets at Bloomberg Invest Global Summit
00:10:00
strategic resources into each company throughout its lifecycle|Chris Zeoli,Partner,Wing Venture Capital
00:10:00
Navigating the Empty Nest Transition: Financial Tips for a New Chapter | Ron Bernstein, Co-founder , Prism Planning Partners.
00:10:00
Sunrun CEO Mary Powell discusses the impact of solar panels on residential houses during an eclipse on 'Money Movers'.
00:10:00
Expansion and Integration Drive Growth for Multi-Brand Franchisor Amidst Strong Interim Results | Stephen Hemsley, CEO, Franchise Brands PLC.